Focussed specifically on children and pediatric respiratory diseases, "The Pediatric Lung+" reviews the current status of pharmacological therapy for asthma, viral pneumonia, cystic fibrosis, bronchopulmonary dysplasia and acute respiratory failure. A review of aerosol delivery systems in children and an up-to-date treatise on mucolytic agents is also included. The chapters are written by leading specialists in the field and summarize the latest developments in pediatric pulmonology, as well as covering a comprehensive range of respiratory diseases in children. Pediatric pulmonologists, allergologists, intensivists, neonatologists and general pediatricians will find "The Pediatric Lung" an invaluable source of reference. Clinicians will be particularly interested in the new information concerning aerosol delivery systems, gene therapy for cystic fibrosis, new modalities of therapy for asthma, the emerging role of nitric oxide and a treatise on modern mycolytic agents.
